Distinctions and similarities of cell bioenergetics and the role of mitochondria in hypoxia, cancer, and embryonic development

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 5, 2010, Pages 604-622

  Ježek, Petr ^a   Plecitá Hlavatá, Lydie ^a   Smolková, Katarína ^a   Rossignol, Rodrigue ^b,c  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b INSERM   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Cancer bioenergetics; Embryonic bioenergetics; Hypoxia; Hypoxia induced factor; Mitochondria; Oxidative stress due to insulin signaling

Indexed keywords

ASPARAGINE; CYTOCHROME C OXIDASE; GLUCOSE; HYDROGEN PEROXIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; IRON; MAMMALIAN TARGET OF RAPAMYCIN; NITRIC OXIDE SYNTHASE; ONCOPROTEIN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROLINE; PYRUVIC ACID; REACTIVE OXYGEN METABOLITE; UBIQUINOL CYTOCHROME C REDUCTASE;

BIOENERGY; BRAIN ISCHEMIA; CELL ENERGY; CELL FUNCTION; CELL HYPOXIA; EMBRYO DEVELOPMENT; GLUCOSE INTAKE; GLYCOLYSIS; HEART MUSCLE ISCHEMIA; HUMAN; HYDROXYLATION; MALIGNANT NEOPLASTIC DISEASE; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR REPROGRAMMING; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN STABILITY; REPERFUSION INJURY; REVIEW; TRANSCRIPTION REGULATION; UBIQUITINATION;

EID: 77649337197     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.11.008     Document Type: Review

References (309)

1. Agani F.H., Pichiule P., Chavez J.C., and LaManna J.C. The role of mitochondria in the regulation of hypoxia-inducible factor 1 expression during hypoxia. J Biol Chem 275 (2000) 35863-35867
2. Aguilar V., Alliouachene S., Sotiropoulos A., Sobering A., Athea Y., Djouadi F., et al. S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase. Cell Metab 5 (2007) 476-487
3. Angelos M.G., Kutala V.K., Torres C.A., He G., Stoner J.D., Mohammad M., et al. Hypoxic reperfusion of the ischemic heart and oxygen radical generation. Am J Physiol 290 (2006) H341-H347
4. Arnould T., Vankoningsloo S., Renard P., Houbion A., Ninane N., Demazy C., et al. CREB activation induced by mitochondrial dysfunction is a new signaling pathway that impairs cell proliferation. EMBO J 21 (2002) 53-63
5. Arrell D.K., Elliott S.T., Kane L.A., Guo Y., Ko Y.H., Pedersen P.L., et al. Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways. Circ Res 99 (2006) 706-714
6. Bavister B.D., and Squirrell J.M. Mitochondrial distribution and function in oocytes and early embryos. Hum Reprod 15 (2000) 189-198
7. Bell E.L., Klimova T.A., Eisenbart J., Moraes C.T., Murphy M.P., Budinger G.R., et al. The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J Cell Biol 177 (2007) 1029-1036
8. Bell E.L., Klimova T., and Chandel N.S. Targeting the mitochondria for cancer therapy: regulation of hypoxia-inducible factor by mitochondria. Antioxid Redox Signal 10 (2008) 635-640
9. Bellance N., Lestienne P., and Rossignol R. Mitochondria from bioenergetics to the metabolic regulation of carcinogenesis. Front Biosci 14 (2009) 4015-4034
10. Bellance N., Benard G., Furt F., Begueret H., Baste J.M., Velly J.F., et al. Reduction of mitochondrial biogenesis and respiratory capacity in lung cancer cell lines and tumors. J Cell Mol Med (2009)
11. Benard G., Bellance N., James D., Parrone P., Fernandez H., Letellier T., et al. Mutual control of mitochondrial bioenergetics and structural network organization. J Cell Sci 120 (2007) 838-848
12. Benard G., and Rossignol R. Ultrastructure of the mitochondrion and its bearing on function and bioenergetics. Antioxid Redox Signal 10 (2008) 1313-1342
13. Bhattacharya S., Michels C.L., Leung M.K., Arany Z.P., Kung A.L., and Livingston D.M. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev 13 (1999) 64-75
14. Bihlmaier K., Mesecke N., Terziyska N., Bien M., Hell K., and Herrmann J.M. The disulfide relay system of mitochondria is connected to the respiratory chain. J Cell Biol 179 (2007) 389-395
15. Bolli R. Role of neutrophils in myocardial stunning after brief ischaemia: the end of a six year old controversy (1987-1993). Cardiovasc Res 27 (1993) 728-730
16. Bolli R. Causative role of oxyradicals in myocardial stunning: a brief review of the evidence demonstrating a major role of reactive oxygen species in several forms of postischemic dysfunction. Bas Res Cardiol 93 (1998) 156-162
17. Bolli R. The late phase of preconditioning. Circ Res 87 (2000) 972-983
18. Bolli R., Bhatti Z.A., Tang X.L., Qiu Y., Zhang Q., Guo Y., et al. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res 81 (1997) 42-52
19. Bolli R., and Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 79 (1999) 609-634
20. Boros L.G., Puigjaner J., Cascante M., Lee W.N., Brandes J.L., Bassilian, et al. Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res 57 (1997) 4242-4248
21. Brader P., Riedl C.C., Woo Y., Ponomarev V., Zanzonico P., Wen B., et al. Imaging of hypoxia-driven gene expression in an orthotopic liver tumor model. Mol Cancer Ther 6 (2007) 2900-2908
22. Brahimi-Horn M., and Pouysségur J. Oxygen, a source of life and stress. FEBS Lett 581 (2007) 3582-3591
23. Brahimi-Horn M.C., and Pouysségur J. HIF at a glance. J Cell Sci 122 (2009) 1055-1057
24. Braun R.D., Lanzen J.L., Snyder S.A., and Dewhirst M.W. Comparison of tumor and normal tissue oxygen tension measurements using Xylite or microelectrodes in rodents. Am J Physiol 280 (2001) H2533-H2544
25. Brooks A.J., Eastwood J., Beckingham I.J., and Girling K.J. Liver tissue partial pressure of oxygen and carbon dioxide during partial hepatectomy. Br J Anaesth 92 (2004) 735-737
26. Brooks K.J., Hargreaves I.P., and Bates T.E. Protection of respiratory chain enzymes from ischemic damage in adult rat brain slices. Neurochem Res 33 (2008) 1711-1716
27. Bruick R.K., and McKnight S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294 (2001) 1337-1340
28. Brunelle J.K., Bell E.L., Quesada N.M., Vercauteren K., Tiranti V., Zeviani M., et al. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab 1 (2005) 409-414
29. Burwell L.S., and Brookes P.S. Mitochondria as a target for the cardioprotective effects of nitric oxide in ischemia-reperfusion injury. Antioxid Redox Signal 10 (2008) 579-599
30. Canto C., Gerhart-Hines Z., Feige J.N., Lagouge M., Noriega L., Milne J.C., et al. AMPK regulates energy expenditure by modulating NAD(+) metabolism and SIRT1 activity. Nature 458 (2009) 1056-1060
31. Carbia-Nagashima A., Gerez J., and Perez-Castro C. RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIFα during hypoxia. Cell 131 (2007) 309-323
32. Carreras M.C., and Poderoso J.J. Mitochondrial nitric oxide in the signaling of cell-integrated responses. Am J Physiol 292 (2007) C1569-C1580
33. Chandel N., Budinger G.R., Kemp R.A., and Schumacker P.T. Inhibition of cytochrome-c oxidase activity during prolonged hypoxia. Am J Physiol 268 (1995) L918-L925
34. Chandel N.S., Budinger G.R.S., Choe S.G., and Schumacker P.T. Cellular respiration during hypoxia. J Biol Chem 272 (1997) 18808-18816
35. Chandel N.S., Maltepe E., Goldwasser E., Mathieu C.E., Simon M.C., and Schumacker P.T. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 95 (1998) 11715-11720
36. Chandel N.S., McClintock D.S., Feliciano C.E., Wood T.M., Melendez J.A., and Rodriguez A.M. Reactive oxygen species generated at mitochondrial complex III stability hypoxia-inducible factor-1alpha during hypoxia: a mechanism of oxygen sensing. J Biol Chem 275 (2000) 25130-25138
37. Chandel N.S., Trzyna W.C., McClintock D.S., and Schumacker P.T. Role of oxidants in NF-kB activation and TNF-α gene transcription induced by hypoxia and endotoxin. J Immunol 165 (2000) 1013-1021
38. Chandel N.S., Vander Heiden M.G., Thompson C.B., and Schumacker P.T. Redox regulation of p53 during hypoxia. Oncogene 19 (2000) 3840-3848
39. Chauvet C., Bois-Joyeux B., Berra E., Pouyssegur J., and Danan J.L. The gene encoding human retinoic acid-receptor-related orphan receptor α is a target for hypoxia-inducible factor 1. Biochem J 384 (2004) 79-85
40. Chen W., Ostrowski R.P., and Zhang J.H. Prodeath or prosurvival:two facets of hypoxia inducible factor-1 in perinatal brain injury. Exp Neurol 216 (2009) 7-15
41. Chen C., Pore N., Behrooz A., Ismail-Beigi F., and Maity A. Regulation of glut1 mRNA by hypoxia-inducible factor-1 Interaction between H-ras and hypoxia. J Biol Chem 276 (2001) 9519-9525
42. Chi M.M., Hoehn A., and Moley K.H. Metabolic changes in the glucose-induced apoptotic blastocyst suggest alterations in mitochondrial physiology. Am J Physiol 283 (2002) E226-E232
43. Choi J., Park S., Kang G., Liu J., and Youn H. Nur77 activated by hypoxia-inducible factor-1α overproduces proopiomelanocortin in von Hippel-Lindau-mutated renal cell carcinoma. Cancer Res 64 (2004) 35-39
44. Coffman J.A., and Denegre J.M. Mitochondria, redox signaling and axis specification in metazoan embryos. Dev Biol 308 (2007) 266-280
45. Cohen M.V., Yang X.M., Liu G.S., Heusch G., and Downey J.M. Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ Res 89 (2001) 273-278
46. Comerford K.M., Wallace T.J., Karhausen J., Louis N.A., Montalto M.C., and Colgan S.P. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 62 (2002) 3387-3394
47. Corn P.G., Ricci M.S., Scata K.A., Arsham A.M., Simon M.C., Dicker D.T., et al. Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc induced apoptosis. Cancer Biol Ther 4 (2005) 1285-1294
48. Costa A.D., and Garlid K.D. MitoKATP activity in healthy and ischemic hearts. J Bioenerg Biomembr 41 (2009) 123-126
49. Costa A.D., Pierre S.V., Cohen M.V., Downey J.M., and Garlid K.D. cGMP signalling in pre- and post-conditioning: the role of mitochondria. Cardiovasc Res 77 (2008) 344-352
50. Cree L.M., Samuels D.C., de Sousa Lopes S.C., Rajasimha H.K., Wonnapinij P., Mann J.R., et al. A reduction of mitochondrial DNA molecules during embryogenesis explains the rapid segregation of genotypes. Nat Genet 40 (2008) 249-254
51. Cuezva J.M., Ostronoff L.K., Ricart J., Lopez de Heredia M., Di Liegro C.M., and Izquierdo J.M. Mitochondrial biogenesis in the liver during development and oncogenesis. J Bioenerg Biomembr 29 (1997) 365-377
52. Daithankar V.N., Farrell S.R., and Thorpe C. Augmenter of liver regeneration: substrate specificity of a flavin-dependent oxidoreductase from the mitochondrial intermembrane space. Biochemistry 48 (2009) 4828-4837
53. Dalakas M.C., Illa I., Pezeshkpour G.H., Laukaitis J.P., Cohen B., and Griffin J.L. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 322 (1990) 1098-1105
54. Dalgard C.L., Lu H., Mohyeldin A., and Verma A. Endogenous 2-oxoacids differentially regulate expression of oxygen sensor. Biochem J 380 (2004) 419-424
55. Dames S.A., Martinez-Yamout M., De Guzman R.N., Dyson H.J., and Wright P.E. Structural basis for HIF-1 alpha/CBP recognition in the cellular hypoxic response. Proc Natl Acad Sci USA 99 (2002) 5271-5276
56. Dave K.R., DeFazio R.A., Raval A.P., Torraco A., Saul I., Barrientos A., et al. Ischemic preconditioning targets the respiration of the synaptic mitochondria via protein kinase C epsilon. J Neurosci 28 (2008) 4172-4182
57. Dayan F., Mazure N.M., Brahimi-Horn M.C., and Pouysségur J. A dialogue between the hypoxia-inducible factor and the tumor microenvironment. Cancer Microenviron 1 (2008) 53-68
58. Dedkova E.N., and Blatter L.A. Characteristics and function of cardiac mitochondrial nitric oxide synthase. J Physiol 587 (2009) 851-872
59. De Grey A.D.N.J. HO2*: the forgotten radical. DNA Cell Biol 21 (2002) 251-257
60. DeHaan C., Habibi-Nazhad B., Yan E., Salloum N., Parlament M., and Allalunis-Turner J. Mutation in mitochondrial complex I ND6 subunit is associated with defective response to hypoxia in human glioma cells. Mol Cancer 3 (2004) 19
61. Delaval E., Razanoelina M., Bastin J., Freund N., Bismuth J., and Geloso J.P. Mitochondrial activity of rat kidney during ontogeny. J Dev Physiol 14 (1990) 1-5
62. Denko N.C. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 8 (2008) 705-713
63. Dewhirst M.W., Cao M., and Moeller B. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer 8 (2008) 425-437
64. Diaz F., and Moraes C.T. Mitochondrial biogenesis and turnover. Cell Calcium 44 (2008) 24-35
65. Diaz-Ruiz R., Averet N., Araiza D., et al. Mitochondrial oxidative phosphorylation is regulated by fructose-1,6-biphosphate: a possible role in Crabtree effect induction?. J Biol Chem 283 (2008) 26948-26955
66. Dlasková A., Hlavatá L., and Ježek P. Oxidative stress caused by blocking of mitochondrial Complex I H+ pumping as a link in aging/disease vicious cycle. Int J Biochem Cell Biol 40 (2008) 2098-2109
67. Downey J.M., Davis A.M., and Cohen M.V. Signaling pathways in ischemic preconditioning. Heart Fail Rev 12 (2007) 181-188
68. Dumollard R., Carroll J., Duchen M.R., Campbell K., and Swann K. Mitochondrial function and redox state in mammalian embryos. Semin Cell Dev Biol 20 (2009) 346-353
69. Dumollard R., Duchen M., and Carroll J. The role of mitochondrial function in the oocyte and embryo. Curr Top Dev Biol 77 (2007) 21-49
70. Dumollard R., Ward Z., Carroll J., and Duchen M. Regulation of redox metabolism in the mouse early embryo. Development 134 (2007) 455-465
71. Duranteau J., Chandel N.S., Kulisz A., Shao Z., and Schumacker P.T. Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 273 (1998) 11619-11624
72. Ebert B.L., and Bunn H.F. Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREBbinding protein. Mol Cell Biol 18 (1998) 4089-4096
73. Ekstrand M.I., Falkenberg M., Rantanen A., Park C.B., Gaspari M., Hultenby K., et al. Mitochondrial transcription factor A regulates mtDNA copy number in mammals. Hum Mol Genet 13 (2004) 935-944
74. Emerling B.M., Weinberg F., Snyder C., Burgess Z., Mutlu G.M., Viollet B., et al. Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio. Free Radic Biol Med 46 (2009) 1386-1391
75. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., et al. C elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107 (2001) 43-54
76. Erecinska M., and Silver I.A. Tissue oxygen tension and brain sensitivity to hypoxia. Respir Physiol 128 (2001) 263-276
77. Fan C., Li Q., Ross D., and Engelhardt J.F. Tyrosine phosphorylation of IB activates NFB through a redox-regulated and c-Src-dependent mechanism following hypoxia/reoxygenation. J Biol Chem 278 (2003) 2072-2080
78. Feldes D., Alani F., Iyer N.V., Pak B., Ferreira G., and Semena G.L. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Canc Res 59 (1999) 3915-3918
79. Feldser D., Agani F., Iyer N.V., Pak B., Ferreira G., and Semenza G.L. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res 59 (1999) 3915-3918
80. Finocchietto P., Barreyro F., Holod S., Peralta J., Franco M.C., Méndez C., et al. Control of muscle mitochondria by insulin entails activation of Akt2-mtNOS pathway: implications for the metabolic syndrome. PLoS ONE 3 (2008) 1749
81. Finocchietto P.V., Franco M.C., Holod S.A., Gonzalez A.S., Converso D.P., Antico Arciuch V.G., et al. Mitochondrial nitric oxide synthase: a master piece of metabolic adaptation, cell growth, transformation and death. Exp Biol Med Maywood June (2009)
82. Folkman J., Hahnfeldt P., and Hlatky L. Cancer looking outside the genome. Nat Rev Mol Cell Biol 1 (2000) 76-79
83. Forneris F., Binda C., Vanoni M.A., Mattevi A., and Battaglioli E. Histone demethylation catalysed by LSD1 is a flavin-dependent oxidative process. FEBS Lett 579 (2005) 2203-2207
84. Foster D.B., Rucker J.J., and Marbán E. Is Kir6.1 a subunit of mitoK(ATP)?. Biochem Biophys Res Commun 366 (2008) 649-656
85. Foster D.B., Van Eyk J.E., Marbán E., and O'Rourke B. Redox signaling and protein phosphorylation in mitochondria: progress and prospects. J Bioenerg Biomembr 41 (2009) 159-168
86. Fradette C., and du Souich P. Hypoxia-inducible factor-1 and activator protein-1 modulate the upregulation of CYP3A6 induced by hypoxia. Br J Pharmacol 140 (2003) 1146-1154
87. Freedman S.J., Sun Z.Y., Poy F., Kung A.L., Livingston D.M., Wagner G., et al. Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha. Proc Natl Acad Sci USA 99 (2002) 5367-5372
88. Friberg H., Connern C., Halestrap A.P., and Wieloch T. Differences in the activation of the mitochondrial permeability transition among brain regions in the rat correlate with selective vulnerability. J Neurochem 72 (1999) 2488-2497
89. Fukuda R., Zhang H., Kim J.W., Shimoda L., Dang C.V., and Semenza G.L. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 129 (2007) 111-122
90. Garlid K.D., Costa A.D., Quinlan C.L., Pierre S.V., and Dos Santos P. Cardioprotective signaling to mitochondria. J Mol Cell Cardiol 46 (2009) 858-866
91. Gerald D., Berra E., Frapart Y.M., Chan D.A., Giaccia A.J., Mansuy D., et al. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118 (2004) 781-794
92. Giulivi C. Mitochondria as generators and targets of nitric oxide. Novartis Found Symp 287 (2007) 92-100
93. Giusti S., Converso D.P., Poderoso J.J., and Fiszer de Plazas S. Hypoxia induces complex I inhibition and ultrastructural damage by increasing mitochondrial nitric oxide in developing CNS. Eur J Neurosci 27 (2008) 123-131
94. Gladwin M.T., and Shiva S. The ligand binding battle at cytochrome c oxidase: how NO regulates oxygen gradients in tissue. Circ Res 104 (2009) 1136-1138
95. Gnaiger E. Capacity of oxidative phosphorylation in human skeletal muscle. New perspectives of mitochondrial physiology. Int J Biochem Cell Biol April (2009)
96. Graham B.H., Waymire K.G., Cottrell B., Trounce I.A., MacGregor G.R., and Wallace D.C. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat Genet 16 (1997) 226-234
97. Grill H.P., Zweier J.L., Kuppusamy P., Wiesfeldt M.L., and Flaherty J.T. Direct measurement of myocardial free radical generation in an in vivo model: effects of postischemic reperfusion and treatment with human recombinant superoxide dismutase. J Am Coll Cardiol 20 (1992) 1604-1611
98. Gross G.J., and Peart J.N. KATP channels and myocardial preconditioning: an update. Am J Physiol 285 (2003) H921-H930
99. Gu Y.Z., Moran S.M., Hogenesch J.B., Wartman L., and Bradfield C.A. Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3α. Gene Expr 7 (1998) 205-213
100. Guzy R.D., Hoyos B., Robin E., Chen H., Liu L., and Mansfield K.D. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 1 (2005) 401-414
101. Guzy R.D., and Schumacker P.T. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol 91 (2006) 807-819
102. Haden D.W., Suliman H.B., Carraway M.S., Welty-Wolf K.E., Ali A.S., Shitara H., et al. Mitochondrial biogenesis restores oxidative metabolism during Staphylococcus aureus sepsis. Am J Respir Crit Care Med 176 (2007) 768-777
103. Hagen T., Taylor C.T., Lam F., and Moncada S. Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1α. Science 302 (2003) 1975-1978
104. Hahn P., and Skala J. Development of enzyme systems. Clin Obstet Gynecol 14 (1971) 655-668
105. Halestrap A.P., Clarke S.J., and Javadov S.A. Mitochondrial permeability transition pore opening during myocardial reperfusion: a target for cardioprotection. Cardiovasc Res 61 (2004) 381-385
106. Hanley P.J., and Daut J. KATP channels and preconditioning: a re-examination of the role of mitochondrial KATP channels and an overview of alternative mechanisms. J Mol Cell Cardiol 39 (2005) 17-50
107. Hansson A., Hance N., Dufour E., Rantanen A., Hultenby K., Clayton D.A., et al. A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts. Proc Natl Acad Sci USA 101 (2004) 3136-3141
108. Hardie D.G. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 8 (2007) 774-785
109. Haroon Z.A., Raleigh J.A., Greenberg C.S., and Dewhirst M.W. Early wound healing exhibits cytokine surge without evidence of hypoxia. Ann Surg 231 (2000) 137-147
110. Harvey A.J. The role of oxygen in ruminant preimplantation embryo development and metabolism. Anim Reprod Sci 98 (2007) 113-128
111. Hatzivassiliou G., Zhao F., Bauer D.E., et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8 (2005) 311-321
112. Hausenloy D.J., Ong S.B., and Yellon D.M. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol 104 (2009) 189-202
113. Hell K. The Erv1-Mia40 disulfide relay system in the intermembrane space of mitochondria. Biochim Biophys Acta 1783 (2008) 60-69
114. Henquell L., Odoroff C.L., and Honig C.R. Coronary intercapillary distance during growth: relation to PtO2 and aerobic capacity. Am J Physiol 231 (1976) 1852-1859
115. Herst P.M., and Berridge M.V. Cell surface oxygen consumption: a major contributor to cellular oxygen consumption in glycolytic cancer cell lines. Biochim Biophys Acta 1767 (2007) 170-177
116. Hervouet E., Čížková A., Demont J., Vojtíšková A., Pecina P., Franssen-van Hal N.L., et al. HIF and reactive oxygen species regulate oxidative phosphorylation in cancer. Carcinogenesis 29 (2008) 1528-1537
117. Hirsila M., Koivunen P., Gunzler V., Kivirikko K.I., and Myllyharju J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem 278 (2003) 30772-30780
118. Hoffman D.L., and Brookes P.S. Oxygen sensitivity of mitochondrial reactive oxygen species generation depends on metabolic conditions. J Biol Chem 284 (2009) 16236-16245
119. Hoffman D.L., Salter J.D., and Brookes P.S. Response of mitochondrial reactive oxygen species generation to steady-state oxygen pension: implication for hypoxic cell signaling. Am J Physiol 292 (2007) H101-H108
120. Hoppeler H., Vogt M., Weibel E.R., and Fluck M. Response of skeletal muscle mitochondria to hypoxia. Exp Physiol 88 (2003) 109-119
121. Houghton F.D., and Leese H.J. Metabolism and developmental competence of the preimplantation embryo. Eur J Obstet Gynecol Reprod Biol 115 (2004) S92-S96
122. Hu C.J., Wang L.Y., Chodosh L.A., Keith B., and Simon M.C. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 23 (2003) 9361-9374
123. Iñarrea P., Moini H., Han D., Rettori D., Aguiló I., Alava M.A., et al. Mitochondrial respiratory chain and thioredoxin reductase regulate intermembrane Cu,Zn-superoxide dismutase activity: implications for mitochondrial energy metabolism and apoptosis. Biochem J 405 (2007) 173-179
124. Isaacs J.S., Jung Y.J., and Mole D.R. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8 (2005) 143-153
125. Ivan M., Haberberger T., Gervasi D.C., Michelson K.S., Gunzler V., Kondo K., et al. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc Natl Acad Sci USA 99 (2002) 13459-13464
126. Ivan M., Kondo K., Yang H., Kim W., Valiando J., Ohh M., et al. 'HIF alpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing'. Science 292 (2001) 464-468
127. Ishikawa K., Takenaga K., Akimoto M., Koshikawa N., Yamaguchi A., Imanishi H., et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320 (2008) 661-664
128. Iyer N.V., Kotch L.E., Agani F., Leung S.W., Laughner E., Wenger R.H., et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1α. Genes Dev 2 (1998) 149-162
129. Jaakkola P., Mole D.R., Tian Y.M., Wilson M.I., Gielbert J., Gaskell S.J., et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292 (2001) 468-472
130. Jeffree R.L., Wills E.J., and Harper C. An unusual myopathy: speckled muscle fibers due to enlarged mitochondria. Muscle Nerve 36 (2007) 118-122
131. Ježek P., and Hlavatá L. Mitochondria in homeostasis of reactive oxygen species in cell tissues and organism. Int J Biochem Cell Biol 37 (2005) 2478-2503
132. Ježek P., and Plecitá-Hlavatá L. Mitochondrial reticulum network dynamics in relation to oxidative stress, redox regulations, and hypoxia. Int J Biochem Cell Biol 41 (2009) 1790-1804
133. Jiang B.H., Semenza G.L., Bauer C., and Marti H.H. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol 271 (1996) C1172-C1180
134. John A.P. Dysfunctional mitochondria, not oxygen insufficiency, cause cancer cells to produce inordinate amounts of lactic acid: the impact of this on the treatment of cancer. Med Hypotheses 57 (2001) 429-431
135. Jung K.W. Perspectives on human stem cell research. J Cell Physiol 220 (2009) 535-537
136. Kaluz S., Kaluzova M., and Stanbridge E.J. Regulation of gene expression by hypoxia: integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element. Clin Chim Acta 395 (2008) 6-13
137. Kaneki M., Shimizu N., Yamada D., and Chang K. Nitrosative stress and pathogenesis of insulin resistance. Antioxid Redox Signal 9 (2007) 319-329
138. Kenneth N.S., and Rocha S. Regulation of gene expression by hypoxia. Biochem J 414 (2008) 19-29
139. Kelley D.E., He J., Menshikova E.V., and Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51 (2002) 2944-2950
140. Kietzmann T., and Goerlach A. Reactive oxygen species in the control of hypoxia-inducible factor mediated gene expression. Semin Cell Dev Biol 16 (2005) 474-486
141. Kietzmann T., Roth U., and Jungermann K. Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes. Blood 94 (1999) 4177-4185
142. Kim J.W., Tchernyshyov I., Semenza G.L., and Dang C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3 (2006) 177-185
143. Kim J.W., Gao P., Liu Y.C., Semenza G.L., and Dang C.V. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol Cell Biol 27 (2007) 7381-7393
144. Klimova T., and Chandel N.S. Mitochondrial complex III regulates hypoxic activation of HIF. Cell Death Differ 15 (2008) 660-666
145. Knudsen T.B., and Green M.L. Response characteristic of the mitochondrial DNA genome in developmental health and disease. Birth Defects Res 72 (2004) 313-329
146. Koene S., and Smeitink J. Mitochondrial medicine: entering the era of treatment. J Intern Med 265 (2009) 193-209
147. Kondo K., Klco J., Nakamura E., Lechpammer M., and Kaelin Jr. W.G. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell 1 (2002) 237-246
148. Koong A.C., Chen E.Y., and Giaccia A.J. Hypoxia causes the activation of nuclear factor κB through the phosphorylation of IκBα on tyrosine residues. Cancer Res 54 (1994) 1425-1430
149. Kress S., Stein A., Maurer P., Weber B., Reichert J., Buchmann A., et al. Expression of hypoxia-inducible genes in tumor cells. J Cancer Res Clin Oncol 124 (1998) 315-320
150. Krishnamachary B., Berg-Dixon S., Kelly B., Agani F., Feldser D., Ferreira G., et al. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 63 (2003) 1138-1143
151. Krishnamurthy P., Ross D.D., Nakanishi T., Bailey-Dell K., Zhou S., Mercer K.E., et al. The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem 279 (2004) 24218-24225
152. Kuçi S., Kuçi Z., Latifi-Pupovci H., Niethammer D., Handgretinger R., Schumm M., et al. Adult stem cells as an alternative source of multipotential (pluripotential) cells in regenerative medicine. Curr Stem Cell Res Ther 4 (2009) 107-117
153. Kulshreshtha R., Ferracin M., Wojcik S.E., Garzon R., Alder H., Agosto-Perez F.J., et al. A microRNA signature of hypoxia. Mol Cell Biol 27 (2007) 1859-1867
154. Kutala V.M., Khan M., Angelos M.G., and Kuppusamy P. Role of oxygen in postischemic myocardial injury. Antiox Redox Signal 9 (2007) 193-206
155. Lacza Z., Pankotai E., and Busija D.W. Mitochondrial nitric oxide synthase: current concepts and controversies. Front Biosci 14 (2009) 4436-4443
156. Lam P.Y., Yin F., Hamilton R.T., Boveris A., and Cadenas E. Elevated neuronal nitric oxide synthase expression during ageing and mitochondrial energy production. Free Radic Res 43 (2009) 431-439
157. Lando D., Peet D.J., Gorman J.J., Whelan D.A., Whitelaw M.L., and Bruick R.K. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 16 (2002) 1466-1471
158. Lando D., Peet D.J., Whelan D.A., Gorman J.J., and Whitelaw M.L. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295 (2002) 858-861
159. Larsen G.A., Skjellegrind H.K., Vinje M.L., and Berg-Johnsen J. Mitochondria are more resistant to hypoxic depolarization in the newborn than in the adult brain. Neurochem Res 33 (2008) 1894-1900
160. Lartigau E., Randrianarivelo H., Avril M., Margulis A., Spatz A., Eschwège F., et al. Intratumoral oxygen tension in metastatic melanoma. Melanoma Res 7 (1997) 400-406
161. Lebuffe G., Schumacker P.T., Shao Z.H., Anderson T., Iwase H., and Vanden Hoek T.L. ROS and NO trigger early preconditioning: relationship to mitochondrial KATP channel. Am J Physiol 284 (2003) H299-308
162. Lee M.J., Kim J.Y., Suk K., and Park J.H. Identification of the hypoxia-inducible factor 1a-responsive HGTD-P gene as a mediator in the mitochondrial apoptotic pathway. Mol Cell Biol 24 (2004) 3918-3927
163. Li F., Wang Y., Zeller K.I., Potter J.J., Wonsey D.R., O'Donnell K.A., et al. Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol Cell Biol 25 (2005) 6225-6234
164. Lin X., David C.A., Donnelly J.B., Michaelides M., Chandel N.S., Huang X., et al. A chemical genomics screen highlights the essential role of mitochondria in HIF-1 regulation. Proc Natl Acad Sci USA 105 (2008) 174-179
165. Lisy K., and Peet D.J. Turn me on: regulating HIF transcriptional activity. Cell Death Differ 15 (2008) 642-649
166. 2+ uptake in myocytes from failing hearts restores energy supply and demand matching. Circ Res 103 (2008) 279-288
167. 2+ and its effects on energetics and redox balance in normal and failing heart. J Bioenerg Biomembr 41 (2009) 127-132
168. Lluis J.M., Buricchi F., Chiarugi P., Morales A., and Fernandez-Checa J.C. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-κB via c-SRC- and oxidant-dependent cell death. Cancer Res 67 (2007) 7368-7377
169. Lofstedt T., Jogi A., Sigvardsson M., Gradin K., Poellinger L., Pahlman S., et al. Induction of ID2 expression by hypoxia-inducible factor-1: a role in dedifferentiation of hypoxic neuroblastoma cells. J Biol Chem 279 (2004) 39223-39231
170. Lombes A., Mendell J.R., Nakase H., Barohn R.J., Bonilla E., Zeviani M., et al. Myoclonic epilepsy and ragged-red fibers with cytochrome oxidase deficiency: neuropathology, biochemistry, and molecular genetics. Ann Neurol 26 (1989) 20-33
171. Lonergan T., Brenner C., and Bavister B. Differentiation-related changes in mitochondrial properties as indicators of stem cell competence. J Cell Physiol 208 (2006) 149-153
172. Lonergan T., Brenner C., and Bavister B. Mitochondria in stem cells. Mitochondrion 7 (2007) 289-296
173. Loor G., and Schumacker P.T. Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion. Cell Death Differ 15 (2008) 686-690
174. Lu H., Dalgard C.L., Mohyeldin A., McFate T., Tait A.S., and Verma A. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J Biol Chem 280 (2005) 41928-41939
175. Lum J.J., Bui T., Gruber M., Gordan J.D., DeBerardinis R.J., Covello K.L., et al. The transcription factor HIF-1α plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes Dev 21 (2007) 1037-1049
176. Maas D.H., Storey B.T., and Mastroianni Jr. L. Oxygen tension in the oviduct of the rhesus monkey (Macaca mulatta). Fertil Steril 27 (1976) 1312-1317
177. Maciver N.J., Jacobs S.R., Wieman H.L., Wofford J.A., Coloff J.L., and Rathmell J.C. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J Leukoc Biol 84 (2008) 949-957
178. Mahon P.C., Hirota K., and Semenza G.L. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 15 (2001) 2675-2686
179. Mansfield K.D., Guzy R.D., Pan Y., Young R.M., Cash T.P., Schumacker P.T., et al. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. Cell Metab 1 (2005) 393-399
180. Maranchie J.K., Vasselli J.R., Riss J., Bonifacino J.S., Linehan W.M., and Klausner R.D. The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell 1 (2002) 247-255
181. Mathupala S.P., Rempel A., and Pedersen P.L. Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions. J Biol Chem 276 (2001) 43407-43412
182. Maxwell P.H., Dachs G.U., Gleadle J.M., Nicholls L.G., Harris A.L., Stratford I.J., et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA 94 (1997) 8104-8109
183. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399 (1999) 271-275
184. Maxwell S.R., and Lip G.Y. Free radicals and antioxidants in cardiovascular disease. Br J Pharmacol 44 (1997) 307-317
185. May-Panloup P., Chretien M.F., Malthiery Y., and Reynier P. Mitochondrial DNA in the oocyte and the developing embryo. Curr Top Dev Biol 77 (2007) 51-83
186. McClintock D.S., Santore M.T., Lee V.Y., Brunelle J., Budinger G.R., Zong W.X., et al. Bcl-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death. Mol Cell Biol 22 (2002) 94-104
187. McConell G.K., and Wadley G.D. Potential role of nitric oxide in contraction-stimulated glucose uptake and mitochondrial biogenesis in skeletal muscle. Clin Exp Pharmacol Physiol 35 (2008) 1488-1492
188. Mercy L., Pauw A., Payen L., Tejerina S., Houbion A., Demazy C., et al. Mitochondrial biogenesis in mtDNA-depleted cells involves a Ca2+-dependent pathway and a reduced mitochondrial protein import. FEBS J 272 (2005) 5031-5055
189. Metzen E., Zhou J., Jelkmann W., Andrey J., and Brune B. Nitric oxide impairs normoxic degradation of HIF 1alpha by inhibition of prolyl hydroxylase. Mol Biol Cell 16 (2003) 474-486
190. Minai L., Martinovic J., Chretien D., Dumez F., Razavi F., Munnich A., et al. Mitochondrial respiratory chain complex assembly and function during human fetal development. Mol Genet Metab 94 (2008) 120-126
191. Miyazaki K., Kawamoto T., Tanimoto K., Nishiyama M., Honda H., and Kato Y. Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes. J Biol Chem 277 (2002) 47014-47021
192. Moncada S., and Bolanos J.P. Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem 97 (2006) 1676-1689
193. Moraes C.T., DiMauro S., Zeviani M., Lombes A., Shanske S., Miranda A.F., et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 320 (1989) 1293-1299
194. Moreno-Sanchez R., Rodriguez-Enriquez S., Marin- Hernandez A., and Saavedra E. Energy metabolism in tumor cells. FEBS J 274 (2007) 1393-1418
195. Mtango N.R., Harvey A.J., Latham K.E., and Brenner C.A. Molecular control of mitochondrial function in developing rhesus monkey oocytes and preimplantation-stage embryos. Reprod Fertil Dev 20 (2008) 846-859
196. Müller J.M., Milenkovic D., Guiard B., Pfanner N., and Chacinska A. Precursor oxidation by Mia40 and Erv1 promotes vectorial transport of proteins into the mitochondrial intermembrane space. Mol Biol Cell 19 (2008) 226-236
197. Murphy E., and Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 88 (2008) 581-609
198. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
199. Nathan A.T., and Singer N. The oxygen trail: tissue oxygenation. Br Med Bull 55 (1999) 96-108
200. Navarro A., and Boveris A. Mitochondrial nitric oxide synthase, mitochondrial brain dysfunction in aging, and mitochondria-targeted antioxidants. Adv Drug Deliv Rev 60 (2008) 1534-1544
201. Nesti C., Pasquali L., Vaglini F., Siciliano G., and Murri L. The role of mitochondria in stem cell biology. Biosci Rep 27 (2007) 165-171
202. Nishida H., Sato T., Ogura T., and Nakaya H. LinksNew aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: mitochondrial ion channels and cardioprotection. J Pharmacol Sci 109 (2009) 341-347
203. Nowikovsky K., Schweyen R.J., and Bernardi P. Pathophysiology of mitochondrial volume homeostasis: potassium transport and permeability transition. Biochim Biophys Acta 1787 (2009) 345-350
204. O'Rourke B. Mitochondrial ion channels. Annu Rev Physiol 69 (2007) 19-49
205. Padhani A.R., Krohn K.A., Lewis J.S., and Alber M. Imaging oxygenation of human tumours. Eur Radiol 17 (2007) 861-872
206. Pain T., Yang X.M., Critz S.D., Yue Y., Nakano A., Liu G.S., et al. Opening of mitochondrial KATP channels triggers the preconditioned state by generating free radicals. Circ Res 87 (2000) 460-466
207. Palacios-Callender M., Quintero M., Hollis V.S., Springett R.J., and Moncada S. Endogenous NO regulates superoxide production at low oxygen concentrations by modifying the redox state of cytochrome c oxidase. Proc Natl Acad Sci USA 101 (2004) 7630-7635
208. Palaniyandi S.S., Sun L., Ferreira J.C., and Mochly-Rosen D. Protein kinase C in heart failure: a therapeutic target?. Cardiovasc Res 82 (2009) 229-239
209. Palmer L.A., and Johns R.A. Hypoxia upregulates inducible (Type II) nitric oxide synthase in an HIF-1 dependent manner in rat pulmonary microvascular but not aortic smooth muscle cells. Chest 114 (1998) S33-S34
210. Papandreou I., Cairns R.A., Fontana L., Lim A.L., and Denko N.C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3 (2006) 187-197
211. Papandreou I., Krishna C., Kaper F., Cai D., Giaccia A.J., and Denko N.C. Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment. Cancer Res 65 (2005) 3171-3178
212. Parihar M.S., Parihar A., Villamena F.A., Vaccaro P.S., and Ghafourifar P. Inactivation of mitochondrial respiratory chain complex I leads mitochondrial nitric oxide synthase to become pro-oxidative. Biochem Biophys Res Commun 367 (2008) 761-767
213. Parmar K., Mauch P., Vergilio J.A., Sackstein R., and Down J.D. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci USA 104 (2007) 5431-5436
214. Petrella B.L., and Lohi J. Brinckerhoff CE Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2α in von Hippel-Lindau renal cell carcinoma. Oncogene 24 (2005) 1043-1052
215. Petrosillo G., Di Venosa N., Ruggiero F.M., Pistolese M., D'Agostino D., Tiravanti E., et al. Mitochondrial dysfunction associated with cardiac ischemia/reperfusion can be attenuated by oxygen control tension: role ox oxygen, free radicals and cardiolipin. Biochim Biophys Acta 1710 (2005) 78-86
216. Pfeiffer T., Schuster S., and Bonhoeffer S. Cooperation and competition in the evolution of ATP-producing pathways. Science 292 (2001) 504-507
217. Piccoli C., Ria R., Scrima R., Cela O., D'Aprile A., Boffoli D., et al. Characterization of mitochondrial and extra-mitochondrial oxygen consuming reactions in human hematopoietic stem cells. J Biol Chem 280 (2005) 26467-26476
218. Pinton P., and Rizutto R. p66Shc, oxidative stress, and aging: importing a lifespan determinant into mitochondria. Cell Cycle 7 (2008) 304-308
219. Plecitá-Hlavatá L., Lessard M., Šantorová J., Bewersdorf J., and Ježek P. Mitochondrial oxidative phosphorylation and energetic status are reflected by morphology of mitochondrial network in INS-1E and HEP-G2 cells viewed by 4Pi microscopy. Biochim Biophys Acta 1777 (2008) 834-846
220. Plotnikov E., Yu Marei M.V., Podgornyi O.V., Aleksandrova M.A., Zorov D.B., and Sukhikh G.T. Functional activity of mitochondria in cultured neural precursor cells. Bull Exp Biol Med 141 (2006) 142-146
221. Poderoso J.J. The formation of peroxynitrite in the applied physiology of mitochondrial nitric oxide. Arch Biochem Biophys 484 (2009) 214-220
222. Presley T., Vedam K., Liu X., Zweier J.L., and Ilangovan G. Activation of Hsp90/NOS and increased NO generation does not impair mitochondrial respiratory chain by competitive binding at cytochrome C Oxidase in low oxygen concentrations. Cell Stress Chaperones May (2009)
223. Racay P., Tatarkova Z., Chomova M., Hatok J., Kaplan P., and Dobrota D. Mitochondrial calcium transport and mitochondrial dysfunction after global brain ischemia in rat hippocampus. Neurochem Res (2009)
224. Rana M., de Coo I., Diaz F., Smeets H., and Moraes C.T. An out-of-frame cytochrome b gene deletion from a patient with parkinsonism is associated with impaired complex III assembly and an increase in free radical production. Ann Neurol 48 (2000) 774-781
225. Reitzer L., Wice B., and Kennel D. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J Biol Chem 254 (1979) 2669-2676
226. Richard D.E., Berra E., and Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alha in vascular smooth muscle cells. J Biochem 275 (2000) 26765-26771
227. Riley J.K., and Moley K.H. Glucose utilization and the PI3-K pathway: mechanisms for cell survival in preimplantation embryos. Reproduction 131 (2006) 823-835
228. Rosenfeld E., Beauvoit B., Rigoulet M., and Salmon J.M. Non-respiratory oxygen consumption pathways in anaerobically-grown Saccharomyces cerevisiae: evidence and partial characterization. Yeast 19 (2002) 1299-1321
229. Rossignol R., Gilkerson R., Aggeler R., Yamagata K., Remington S.J., and Capaldi R.A. Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res 64 (2004) 985-993
230. Samoszuk M.K., Walter J., and Mechetner E. Improved immunohistochemical method for detecting hypoxia gradients in mouse tissues and tumors. J Histochem Cytochem 52 (2004) 837-839
231. Santiago A.P.S.A., Chaves E.A., Oliveira M.F., and Galina A. Reactive oxygen species generation is modulated by mitochondrial kinases: correlation with mitochondrial antioxidant peroxidases in rat tissues. Biochemie 90 (2008) 1566-1577
232. Scarpulla R.C. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 88 (2008) 611-638
233. Schieke S.M., Phillips D., McCoy Jr. J.P., Aponte A.M., Shen R.F., Balaban R.S., et al. The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem 281 (2006) 27643-27652
234. Schofield C.J., and Zhang Z. Structural and mechanistic studies on 2-oxoglutarate-dependent oxygenases and related enzymes. Curr Opin Struct Biol 9 (1999) 722-731
235. Schroedl C., McClintock D.S., Budinger G.R., and Chandel N.S. Hypoxic but not anoxic stabilization of HIF-1alpha requires mitochondrial reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 283 (2002) L922-L9231
236. Seagroves T.N., Ryan H.E., Lu H., Wouters B.G., Knapp M., Thibault P., et al. Transcription factor HIF1 is necessary mediator of the Pasteur effect in mammalian cells. Mol Cell Biol 21 (2001) 3436-3444
237. Selak M.A., Armour S.M., and MacKenzie E.D. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF alpha prolyl hydroxylase. Cancer Cell 7 (2005) 77-85
238. Seliskar M., and Rozman D. Mammalian cytochromes P450-importance of tissue specificity. Biochim Biophys Acta 1770 (2007) 458-466
239. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3 (2003) 721-732
240. Semenza G.L. Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. Biochem J 405 (2007) 1-9
241. Semenza G.L., Jiang B.H., Leung S.W., Passantino R., Concordet J.P., Maire P., et al. Hypoxia response elements in the aldolase A, enolase 1 and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271 (1996) 32529-32537
242. Semenza G.L., Nejfelt M.K., Chi S.M., and Antonarakis S.E. Hypoxia-inducible nuclear factors bind to an enhancer element located 30 to the human erythropoietin gene. Proc Natl Acad Sci USA 88 (1991) 5680-5684
243. Semenza G.L., Roth P.H., Fang H.M., and Wang G.L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269 (1994) 23757-23763
244. Semenza G.L., and Wang G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12 (1992) 5447-5454
245. Shaw R.J. Glucose metabolism and cancer. Curr Opin Cell Biol 18 (2006) 598-608
246. Shen J., Khan N., Lewis L.D., Armand R., Grinberg O., Demidenko E., et al. Oxygen consumption rates and oxygen concentration in molt-4 cells and their mtDNA depleted (rho0) mutants. Biophys J 84 (2003) 1291-1298
247. Shiva S., and Gladwin M.T. Nitrite mediates cytoprotection after ischemia/reperfusion by modulating mitochondrial function. Basic Res Cardiol 104 (2009) 113-119
248. Shiva S., Sack M.N., Greer J.J., Duranski M., Ringwood L.A., Burwell L., et al. Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med 204 (2007) 2089-2102
249. Shoubridge E.A., Karpati G., and Hastings K.E. Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fiber segments in mitochondrial disease. Cell 62 (1990) 43-49
250. Shoubridge E.A., and Wai T. Mitochondrial DNA and the mammalian oocyte. Curr Top Dev Biol 77 (2007) 87-111
251. Simon M.C. Mitochondrial reactive oxygen species are required for hypoxic HIFα stabilization. Adv Exp Med Biol 588 (2006) 165-170
252. Smolková K, Plecitá-Hlavatá L, Benard G, Rossignol R, Ježek P. Role of mitochondria in cancer and metabolic signaling. Int J Biochem Cell Biol, in press.
253. Sowter H.M., Raval R.R., Moore J.W., Ratcliffe P.J., and Harris A.L. Predominant role of hypoxia inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia. Cancer Res 63 (2003) 6130-6134
254. Spiegelman B.M. Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators. Novartis Found Symp 287 (2007) 60-63
255. Srivastava S., Diaz F., Iommarini L., Aure K., Lombes A., and Moraes C.T. PGC-1alpha/beta induced expression partially compensates for respiratory chain defects in cells from patients with mitochondrial disorders. Hum Mol Genet 18 (2009) 1805-1812
256. Stewart J.B., Freyer C., Elson J.L., and Larsson N.G. Purifying selection of mtDNA and its implications for understanding evolution and mitochondrial disease. Nat Rev Genet 9 (2008) 657-662
257. Stewart J.B., Freyer C., Elson J.L., Wredenberg A., Cansu Z., Trifunovic A., et al. Strong purifying selection in transmission of mammalian mitochondrial DNA. PLoS Biol 6 (2008) e10
258. St John J.C., Lloyd R.E.I., Bowles E.J., Thomas E.C., and El Shourbagy S. The consequences of nuclear transfer for mammalian foetal development and offspring survival. A mitochondrial DNA perspective. Reproduction 127 (2004) 631-641
259. St John J., Ramalho-Santos J., Gray H., Petrosko P., Rawe V.Y., Navara C.S., et al. The expression of mitochondrial DNA transcription factors during early cardiomyocyte in vitro differentiation from human embryonic stem cells. Cloning Stem Cells 7 (2005) 141-153
260. Such S.W., Shin B.S., Ma H., Van Hoecke M., Brennan A.M., Yenari M.A., et al. Glucose and NADPH oxidase drive neuronal superoxide formation in stroke. Am Neurol 64 (2008) 654-663
261. Sun J.Z., Tang X.L., Park S.W., Qiu Y., Turrens J.F., and Bolli R. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest 97 (1996) 562-576
262. Takahashi Y., Takahashi S., Shiga Y., Yoshimi T., and Miura T. Hypoxic induction of prolyl 4-hydroxylase α(I) in cultured cells. J Biol Chem 275 (2000) 14139-14146
263. Takeuchi T., Neri Q.V., Katagiri Y., Rosenwaks Z., and Palermo G.D. Efect of treating induced mitochondrial damage on embryonic development and epigenesis. Biol Reprod 72 (2005) 584-592
264. Talks K.L., Turley H., Gatter K.C., Maxwell P.H., Pugh C.W., Ratcliffe P.J., et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 157 (2000) 411-421
265. Taylor C.T. Mitochondria and cellular oxygen sensing in the HIF pathway. Biochem J 409 (2008) 19-26
266. Thirunavukkarasu C., Wang L.F., Harvey S.A., Watkins S.C., Chaillet J.R., Prelich J., et al. Augmenter of liver regeneration: an important intracellular survival factor for hepatocytes. J Hepatol 48 (2008) 578-588
267. Thompson L., Dong Y., and Evans L. Chronic hypoxia increases inducible NOS-derived nitric oxide in fetal guinea pig hearts. Pediatr Res 65 (2009) 188-192
268. Tian H., McKnight S.L., and Russell D.W. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 11 (1997) 72-82
269. Towler M.C., and Hardie D.G. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 100 (2007) 328-341
270. Trifunovic A., Wredenberg A., Falkenberg M., Spelbrink J.N., Rovio A.T., Bruder C.E., et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429 (2004) 417-423
271. Trimarchi J., Liu L., Porterfield D., Smith P., and Keefe D. Oxidative phosphorylation dependent and independent oxygen consumption by individual preimplantation mouse embryos. Biol Reprod 62 (2000) 1866-1874
272. Tu B.P., and Weissman J.S. The FAD- and O2-dependent reaction cycle of Ero1-mediated oxidative protein folding in the endoplasmic reticulum. Mol Cell 10 (2002) 983-994
273. Tury A., Mairet-Coello G., Lisowsky T., Griffond B., and Fellmann D. Expression of the sulfhydryl oxidase ALR (Augmenter of Liver Regeneration) in adult rat brain. Brain Res 1048 (2005) 87-97
274. Ullah M.S., Davies A.J., and Halestrap A.P. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1α-dependent mechanism. J Biol Chem 281 (2006) 9030-9037
275. Um S.H., D'Alessio D., and Thomas G. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab 3 (2006) 393-402
276. Van Blerkom J. Mitochondria as regulatory forces in oocytes, preimplantation embryos and stem cells. Reprod Biomed Online 16 (2008) 553-569
277. Van den Hoek T.L., Becker L.B., Shao Z., Li C., and Schumacker P.T. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem 273 (1998) 18092-18098
278. Vankoningsloo S., De Pauw A., Houbion A., Tejerina S., Demazy C., de Longueville F., et al. CREB activation induced by mitochondrial dysfunction triggers triglyceride accumulation in 3T3-L1 preadipocytes. J Cell Sci 119 (2006) 1266-1282
279. Vankoningsloo S., Piens M., Lecocq C., Gilson A., De Pauw A., Renard P., et al. Mitochondrial dysfunction induces triglyceride accumulation in 3T3-L1 cells: role of fatty acid beta-oxidation and glucose. J Lipid Res 46 (2005) 1133-1149
280. Vassilopoulos A., and Papazafiri P. Attenuation of oxidative stress in HL-1 cardiomyocytes improves mitochondrial function and stabilizes HIF 1alpha. Free Radic Res 39 (2005) 1273-1284
281. Vaupel P., Mayer A., and Höckel M. Impact of hemoglobin levels on tumor oxygenation: the higher, the better?. Strahlenther Onkol 182 (2006) 63-71
282. Venkatakrishnan P., Nakayasu E.S., Almeida I.C., and Miller R.T. Absence of nitric oxide synthase in sequentially purified rat liver mitochondria. J Biol Chem 284 (2009) 19843-19855
283. Ventura-Clapier R., Garnier A., and Veksler V. Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. Cardiovasc Res 79 (2008) 208-217
284. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 61 (2004) 481-497
285. Von Heimburg D., Hemmrich K., Zachariah S., Staiger H., and Pallua N. Oxygen consumption in undifferentiated versus differentiated adipogenic mesenchymal precursor cells. Respir Physiol Neurobiol 146 (2005) 107-116
286. Wai T., Teoli D., and Shoubridge E.A. The mitochondrial DNA genetic bottleneck results from replication of a subpopulation of genomes. Nat Genet 40 (2008) 1484-1488
287. Wallace D.C. Mitochondrial diseases in man and mouse. Science 283 (1999) 1482-1488
288. Wallace D.C., Brown M.D., and Lott M.T. Mitochondrial DNA variation in human evolution and disease. Gene 238 (1999) 211-230
289. Wang G.L., Jiang B.H., Rue E.A., and Semenza G.L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92 (1995) 5510-5514
290. Wang G.L., and Semenza G.L. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270 (1995) 1230-1237
291. Ward J.P.T. Oxygen sensors in context. Biochim Biophys Acta 1777 (2008) 1-14
292. Wellen K.E., Hatzivassiliou G., Sachdeva U.M., Bui T.V., Cross J.R., and Thompson C.B. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324 (2009) 1076-1080
293. Wenger R.H., Stiehl D.P., and Camenish G. Integration of oxygen signaling at the consensus HRE. Sci STKE 306 (2005) re12
294. Wenz T., Diaz F., Spiegelman B.M., and Moraes C.T. Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab 8 (2008) 249-256
295. Wilding M., Coppola G., Dale B., and Di Matteo L. Mitochondria and human preimplantation embryo development. Reproduction 137 (2009) 619-624
296. Won S.J., Kim D.Y., and Gwang B.J. Cellular and molecular pathways in ischemic neuronal death. J Biochem Mol Biol 35 (2002) 67-86
297. Wredenberg A., Wibom R., Wilhelmsson H., Graff C., Wiener H.H., Burden S.J., et al. Increased mitochondrial mass in mitochondrial myopathy mice. Proc Natl Acad Sci USA 99 (2002) 15066-15071
298. Wu M., Neilson A., Swift A.L., Moran R., Tamagnine J., Parslow D., et al. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 292 (2007) C125-C136
299. Young V.R., and Ajami A.M. Glutamine: the emperor or his clothes?. J Nutr 131 (2001) 2449S-2459S discussion 2486S-7S
300. Yu D.Y., and Cringle S.J. Retina degeneration and local oxygen metabolism. Exp Eye Res 80 (2005) 745-751
301. Yu S., Zhao T., Guo M., Fang H., Ma J., Ding A., et al. Hypoxic preconditioning up-regulates glucose transport activity and glucose transporter (GLUT1 and GLUT3) gene expression after acute anoxic exposure in the cultured rat hippocampal neurons and astrocytes. Brain Res 1211 (2008) 22-29
302. Yu T., Sheu S.S., Robotham J.L., and Yoon Y. Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species. Cardiovasc Res 79 (2008) 341-351
303. Zeng X. Human embryonic stem cells: mechanism to escape replicative senescence?. Stem Cell Rev 3 (2007) 270-279
304. Zezler E., Levy Y., Kahana C., Shilo B.Z., Tubistcin M., and Cohen B. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF1-alpha/ARNT. EMBO J 17 (1998) 5085-5094
305. Zhang H., Gao P., Fukuda R., Kumar G., Krishnamachary B., Zeller K.I., et al. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 11 (2007) 407-420
306. Zhao X., He G., Chen Y.R., Pandian R.P., Kuppusamy P., and Zweier J.L. Endothelium-derived nitric oxide regulates postischemic myocardial oxygenation and oxygen consumption by modulation of mitochondrial electron transport. Circulation 111 (2005) 2966-2972
307. Zielke H.R., Ozand P.T., Tildon J.T., Sevdalian D.A., and Cornblath M. Growth of human diploid fibroblasts in the absence of glucose utilization. Proc Natl Acad Sci USA 73 (1976) 4110-4114
308. Zielke H.R., Zielke C.L., and Ozand P.T. Glutamine: a major energy source for cultured mammalian cells. Fed Proc 43 (1984) 121-125
309. Zu X.L., and Guppy M. Cancer metabolism: facts, fantasy, and fiction. Biochem Biophys Res Commun 313 (2004) 459-465